Solid Tumors
Stay up to date on the latest advances in malignant solid tumor management with a focus on the role of the advanced practitioner on the multidisciplinary team.
Lung Cancer 40 results
Evaluating the User-Perceived Benefit of a Virtual Lung Cancer Patient Education and Support Community: LVNG With Lung Cancer
By Mona L. Martin, RN, MPA, Kristin Bucklen, BS, MBA, Lise J. Hall, BA, MBA, Dann Wonser, MA, LPC, Genevieve de Renne, MA, OTR/L, FAOTA, Beth Sandy, MSN
July 21, 2024
Infusion-Related Reaction Management With Amivantamab for EGFR Exon 20 Insertion Mutation NSCLC: A Practical Guide for Advanced Practitioners
By Lindsay Dougherty, CRNP, DNP, Whitney E. Lewis, PharmD, BCOP, Meghan O’Neill, CRNP, MSN, Amitabha Bhaumik, PhD, Denise D’Andrea, MD, Andy L. Johnson, PhD
May 22, 2024
Advancing Precision-Targeted Treatment for Patients With Metastatic Non–Small Cell Lung Cancer
Presented by Tajuana Bradley,(1) MSN, APRN-BC, and Beth Sandy,(2) MSN, CRNP, FAPO
April 17, 2024
Biomarker Pursuit: Keeping Current With Novel Biomarkers in Hematology/Oncology
Presented by Beth Faiman,(1) PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO, Sandra E. Kurtin,(2) PhD, ANP-C, AOCN®, FAPO, and Rasheda Persinger,(3) MSN, AGNP-C, AOCNP®
April 26, 2023
Updating the Targeted Therapy Paradigm for Patients With Metastatic NSCLC
Presented by Narjust Florez (Duma), MD, and Stephanie McDonald, NP
April 26, 2023
Managing the Patient With Multiple Primary Tumors
Presented by Holly Chitwood, DNP, APRN, FNP, AGACNP, and Tamara Carey, MSN, APRN, FNP
April 24, 2023
Using Pleomorphic Adenoma Gene 1 (PLAG1) to Distinguish Carcinoma of the Parotid Gland From Primary Lung Cancer: A Case Study
Avigayil East, DNP
March 22, 2023
A Rare Event of Liver Dysfunction on Sotorasib and Management Strategy
Holly Kinahan, MSN, ANP-C, AOCNP®
November 22, 2022
Liquid Biopsy for Guiding Treatment Decisions in Advanced Non–Small Cell Lung Cancer
Gretchen Suk, DMSc, PA-C
November 21, 2022
Thoracic Cancer: 2022 ASCO Annual Meeting Highlights for the Advanced Practitioner
Elizabeth S. Waxman, RN, MSN, AOCN®, ANP-BC
August 23, 2022
The Current Landscape for METex14 Skipping Mutations in Non–Small Cell Lung Cancer
Alisha Desai,(1) PharmD, and Sandra Cuellar,(2) PharmD, BCOP, FHOPA, FASHP
July 20, 2022
Improving Cancer Care Delivery: Learnings for Oncology Nurses and Patient Navigation From a National Quality Survey
Jennifer Aversano,(1,2) MSN, RN, OCN®, BMTCN®, Leigh M. Boehmer,(3) PharmD, BCOP, and Alexander Spira,(4,5) MD, PhD, FACP
July 18, 2022
Multidisciplinary Management of Resectable Early-Stage Non-Small Cell Lung Cancer
Jennifer Jacky,(1) MSN, ARNP, AOCNP®, Kristin DeGroot,(2) PA-C, and Rebecca Denney,(2) PA-C
April 26, 2022
Lung Cancer Biomarker Speak: Teach Me the Language
Beth Sandy,(1) MSN, CRNP, and Jennifer Morrissette,(2) PhD, FACMG
April 21, 2022
Thoracic Cancer: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner
Elizabeth S. Waxman, RN, MSN, AOCN®, ANP-BC
August 24, 2021
The Landscape of the Advanced NSCLC Treatment Paradigm: Molecular Testing and Actionable Mutations
Presented by Rasheda Persinger, AGNP-C
April 21, 2021
Roadmap to the Enhanced Thoracic Surgical Journey
TaCharra Y. D. Woodard, MSN, APRN, ACNP-BC, AOCNP®, Carla M. Patel, MSN, APRN, ACNP-BC, and Garrett L. Walsh, MD
January 19, 2021
Thoracic Cancers: ASCO20 Virtual Scientific Program Highlights for the Advanced Practitioner
Elizabeth S. Waxman, RN, MSN, AOCN®, ANP-BC
August 26, 2020
Using Social Media as a Platform for Increasing Knowledge of Lung Cancer Screening in High-Risk Patients
Aimee Strong,(1) DNP, RN, AGACNP-BC, and Michelle Renaud,(2) RN, PhD
July 20, 2020
Larotrectinib and Entrectinib: TRK Inhibitors for the Treatment of Pediatric and Adult Patients With NTRK Gene Fusion
Danielle B. Dunn, PharmD
May 27, 2020
First-Line Therapy for Metastatic Non–Small Cell Lung Cancer: State-of-the-Art Targeted Therapy and Immunotherapy Approaches
Presented by Joshua Bauml, MD, and Christina Knepley, CRNP
April 21, 2020
2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Non–Small Cell Lung Cancer
Elizabeth S. Waxman, RN, MSN, AOCN®, ANP-BC
August 26, 2019
Management of Side Effects for Patients Receiving Multimodality Therapy in Thoracic Oncology
Presented by Marianne Davies, DNP, RN, CNS, ACNP, AOCNP®, and Beth Eaby-Sandy, MSN, CRNP
April 22, 2019
Systemic Treatments for Lung Cancer Patients Receiving Hemodialysis
Tzewah V. Leung, PharmD, BCOP, Mitchell E. Hughes, PharmD, BCPS, BCOP, Christine G. Cambareri, PharmD, BCPS, BCOP, Daniel J. Rubin, PharmD, and Beth Eaby-Sandy, MSN, CRNP, OCN®
September 14, 2018
A Nurse Practitioner’s Experience in the Development and Implementation of a Lung Cancer Screening Program
Aimee Strong, MSN, AGACNP-BC
July 24, 2018
Current Issue
Immediate Patient Access to Test Results and the Impact on Advanced Practitioners
Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO
November 26, 2024
Obinutuzumab Infusion-Related Reactions Multicenter Retrospective Evaluation of Incidence, Severity, and Risk Factors
Erin Hickey Zacholski, PharmD, BCOP, Sarah Rugh, PharmD Candidate, Jenna Marshall, PharmD Candidate, Et al.
November 26, 2024
Pancreatic Cancer The Advanced Practitioners Role in Early Diagnosis and Management
Lindsay Knox, FNP-C
November 26, 2024